[neverdem]

The researchers now want to test combination therapy with the drugs - cetuximab (trade name Erbitux) and celecoxib (Celebrex) - to treat breast cancer metastasis.

The Telegraph gave you the trade name and the corresponding generic name in their version of this story. Erbitux is a monoclonal antibody that targets a protein called the epidermal growth factor receptor (EGFR).

That's from a FDA Q & A on it.

[BenLurkin]

bookmark

[cyborg]

I’m into prevention. I’m not anti-cancer. I do not embrace a mindset of cancer prevention doing the things I do. I embrace life and living life to the fullest, having the best day ever. I honestly do not believe most of this country is oriented towards prevention because it’s too much work and not supported by health insurance.

[presently no screen name]

+

[TBP]

Inteesting information.

[zeaal]

Thank you for posting.

[gate2wire]

Mark.